Vertex’s non-opioid pain drug gets some UnitedHealth coverage
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
The Business Journals20d
Vertex grew headcount 13% for the second straight year
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its payroll year over year. The Boston-based drugmaker employed 6,100 ...
The Business Journals28d
Top Vertex exec to retire after more than 12 years with company
During the earnings call, Kewalramani also said Vertex hit a big milestone in 2024, recording double-digit revenue growth for the 10th consecutive year. The Boston drugmaker's 2024 product revenue ...
A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan Pier
Boston's most valuable biotech? Vertex. “As Vertex scales for future ... it would leave a huge chunk of empty lab and office ...